The KRIT1 gene helps keep small blood vessels strong and stable. This gene plays an important role in the walls of tiny vessels, and if it does not work properly, fragile clusters of blood vessels can form, especially in the brain and spinal cord. This can lead to cerebral cavernous malformations, which may cause no symptoms or may be linked to headaches, seizures, weakness, or bleeding seen on brain scans. Pathogenic variants in the KRIT1 gene can run in families.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the information needed to make proteins, the working parts inside cells. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. You can find more on this topic in the LearnHub.
Overview
KRIT1Gene function
What if the gene works
The KRIT1 gene helps blood vessel cells stick together and stay stable. Its protein supports the lining of small vessels, especially in the brain, and helps reduce leakage.
Risk
What if the gene does not work
Pathogenic variants in the KRIT1 gene can cause cerebral cavernous malformations, with fragile blood vessel clusters in the brain or spinal cord. Effects range from none to headaches, seizures, bleeding, or stroke-like symptoms, and may vary with variant severity.
Treatment
What does that mean for your treatment
No treatment or medication choice tied specifically to a pathogenic variant in the KRIT1 gene is currently established in clinical guidelines. Care is guided by symptoms, bleeding history, and imaging findings rather than by the KRIT1 gene alone. Research in cerebral cavernous malformations is exploring drugs that target pathways affected by the KRIT1 gene, including ROCK signaling.
Conditions associated with KRIT1
Gene function
What if the gene works
The KRIT1 gene function is especially important in the lining of blood vessels. It helps neighboring cells stay connected, keep their shape, and respond in an orderly way to blood flow. This supports small vessels throughout the body as they handle everyday wear and pressure.
The KRIT1 gene helps blood vessel lining cells hold onto each other at contact points. These steady connections support a smooth inner vessel surface and a more controlled barrier.
KRIT1 acts like a connector between proteins that keep the vessel lining organized. This supports small blood vessels as they adjust to normal blood flow and daily physical stress.
KRIT1 helps organize the internal support framework that gives cells their shape. This lets blood vessel lining cells stay aligned and positioned properly.
KRIT1 helps pass along signals that tell neighboring cells when to tighten, anchor, or rearrange their contacts. This keeps the vessel lining responsive while preserving its overall structure.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not lead to any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many pathogenic variants in the KRIT1 gene make the protein too short or unstable, so it is broken down early or cannot bind its partner proteins. This weakens the tight connections and signaling that help cells lining small blood vessels stay organized. Some KRIT1 gene variants in cerebral cavernous malformation leave partial function, while more disruptive variants can remove function almost completely. That loss of function may shape how early the condition appears and how extensive it becomes, although severity varies.
How variants are linked to conditions
Variants in the KRIT1 gene can cause cerebral cavernous malformation type 1, an inherited condition in which clusters of abnormal blood vessels form mainly in the brain and sometimes the spinal cord. In many families, KRIT1 gene variants are linked to multiple cerebral cavernous malformations, which may come to attention after headaches, seizures, stroke-like symptoms, or bleeding, or may be found on imaging for another reason. Some people also have similar vascular spots on the skin.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely seen across the general population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KRIT1, the main driver of risk is inheriting a disease-causing gene change, often in families with cerebral cavernous malformations, which are clusters of fragile blood vessels in the brain or spinal cord. There is not yet broadly confirmed evidence on specific everyday factors that clearly increase or reduce this genetic risk.
Inheritance of KRIT1 variants
KRIT1-related cerebral cavernous malformation is inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the KRIT1 gene has a 50% chance of passing it on to each child, regardless of sex. In practical terms, this is how KRIT1 gene variants are inherited in families: one changed copy can be enough to run in multiple generations. Some people who inherit the variant develop symptoms, while others may have few or no noticeable signs.
What does my KRIT1 result mean for my family?
A disease-causing change in the KRIT1 gene is usually passed in a dominant pattern, so close relatives like parents, brothers, sisters, and children may also carry the same change and may want to consider genetic counseling or testing. Family members can be affected very differently, even within the same family. In some families, the change is new in one person rather than inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the KRIT1 gene usually uses a blood or saliva sample. A lab reads the gene to look for changes linked to cerebral cavernous malformations, and results may show a disease causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the KRIT1 gene can be worth considering if you or close relatives have cerebral cavernous malformations—clusters of abnormal blood vessels in the brain or spinal cord—especially when there are several lesions, bleeding, seizures, or a family history. A KRIT1 result can help clarify whether the condition runs in the family.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much it reveals varies depending on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some gene changes influence how quickly a drug is broken down, while others can change how strongly your body responds to it. This can affect how well a medicine works or how likely side effects are, which is why medication response often varies even among people taking the same dose.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences can shape a person’s response to medications. It examines connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects may be. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KRIT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. Questions about symptoms, treatment choices, or possible medication side effects are best discussed with your doctor or pharmacist.
History
KRIT1 entered medical genetics through studies of families with cerebral cavernous malformations, a condition involving clusters of small blood vessels in the brain and spinal cord. In the 1990s, researchers traced one inherited form of the condition to chromosome 7, which marked an important step toward finding the responsible gene. Building on this early work, scientists identified the KRIT1 gene in 1999 and linked harmful variants in it to what became known as CCM1. The gene’s name came from laboratory work showing an interaction with a protein called KRAS, though its clinical importance became clearer through family studies. These discoveries helped explain why the condition can run in families and opened the way for more precise genetic diagnosis.